Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-551P is a non-coding RNA pseudogene annotated in the human genome derived from the U6 small nuclear RNA (snRNA) gene. The parent U6 snRNA is a highly conserved component of the spliceosome, involved in mRNA intron removal in eukaryotic cells[3][5]. U6 snRNA is essential for splicing function and undergoes several post-transcriptional modifications, but the pseudogene RNU6-551P itself does not encode protein and does not have a demonstrated biological or drug target role. Some pseudogenes, including those of snRNA families, can be transcribed and may function as regulatory RNAs in certain contexts, potentially affecting epigenetic regulation or acting as miRNA decoys, but there is no published evidence of such activity for RNU6-551P specifically[2][4]. There are no known disease links, drug interactions, or clinical biomarker uses for this pseudogene. Clarifying Notes: - The entry is accurate and sufficiently annotated, but it is not a receptor, enzyme, or traditional therapeutic target[1][4]. - Some pseudogenes can affect gene expression or chromatin structure indirectly through RNA-mediated mechanisms[2], but direct involvement or biological functions for RNU6-551P have not been described. - The molecule should not be considered a primary target for drug discovery or disease therapy.
None (no drugs target this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 551, pseudogene (RNU6-551P).